Involvement of Hdac3-mediated Inhibition of MicroRNA Cluster 17-92 in Bronchopulmonary Dysplasia Development

Overview

Journal Mol Med

Publisher Biomed Central

Specialties General Medicine
Molecular Biology

Date 2020 Nov 4

PMID 33143661

Citations 7

Authors

Di Wang

Hui Hong

Xiao-Xia Li

Jing Li

Zhi-Qun Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of bronchopulmonary dysplasia (BPD), a chronic lung disease of newborns, has been paradoxically rising despite medical advances. Histone deacetylase 3 (Hdac3) has been reported to be a crucial regulator in alveologenesis. Hence, this study aims to investigate the mechanism of Hdac3 in the abnormal pulmonary angiogenesis and alveolarization of BPD.

Methods: A hyperoxia-induced BPD model of was developed in newborn mice, and primary lung fibroblasts were isolated from adult mice. Hdac3 was knocked out in vivo and knocked down in vitro, while microRNA (miR)-17 was downregulated in vivo and in vitro to clarify their roles in abnormal pulmonary angiogenesis and alveolarization. Mechanistic investigations were performed on the interplay of Hdac3, miR-17-92 cluster, enhancer of zeste homolog 1 (EZH1), p65 and placental growth factor (Pgf).

Results: Hdac3 was involved in abnormal alveolarization and angiogenesis in BPD mice. Further, the expression of the miR-17-92 cluster in BPD mice was downregulated by Hdac3. miR-17 was found to target EZH1, and Hdac3 rescued the inhibited EZH1 expression by miR-17 in lung fibroblasts. Additionally, EZH1 augmented Pgf expression by recruiting p65 thus enhancing the progression of BPD. Hdac3 augmented the recruitment of p65 in the Pgf promoter region through the miR-17/EZH1 axis, thus enhancing the transcription and expression of Pgf, which elicited abnormal angiogenesis and alveolarization of BPD mice.

Conclusions: Altogether, the present study revealed that Hdac3 activated the EZH1-p65-Pgf axis through inhibiting miR-17 in the miR-17-92 cluster, leading to accelerated abnormal pulmonary angiogenesis and alveolarization of BPD mice.

Citing Articles

Research progress of microvascular development in bronchopulmonary dysplasia.

Zhang J, Du W, Zhang Z, Li T, Li X, Xi S Pediatr Investig. 2024; 8(4):299-312.

PMID: 39720284 PMC: 11664543. DOI: 10.1002/ped4.12441.

miRNA Signatures in Bronchopulmonary Dysplasia: Implications for Biomarkers, Pathogenesis, and Therapeutic Options.

Maeda H, Li X, Go H, Dennery P, Yao H Front Biosci (Landmark Ed). 2024; 29(7):271.

PMID: 39082345 PMC: 11799892. DOI: 10.31083/j.fbl2907271.

Epigenetic modifications in the development of bronchopulmonary dysplasia: a review.

Wang L, Xiao J, Zhang B, Hou A Pediatr Res. 2024; 96(3):632-642.

PMID: 38570557 DOI: 10.1038/s41390-024-03167-7.

HDAC6 Enhances Endoglin Expression through Deacetylation of Transcription Factor SP1, Potentiating BMP9-Induced Angiogenesis.

Sun C, Xie K, Yang L, Cai S, Wang M, Zhu Y Cells. 2024; 13(6.

PMID: 38534334 PMC: 10969049. DOI: 10.3390/cells13060490.

HDAC3 promotes macrophage pyroptosis via regulating histone deacetylation in acute lung injury.

Li N, Liu B, He R, Li G, Xiong R, Fu T iScience. 2023; 26(7):107158.

PMID: 37404376 PMC: 10316655. DOI: 10.1016/j.isci.2023.107158.

References

Khaliq A, Li X, Shams M, Sisi P, Acevedo C, Whittle M . Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors. 1996; 13(3-4):243-50,color plates I-II,pre.bk cov. DOI: 10.3109/08977199609003225. View

Rogers L, Robbins M, Dakhlallah D, Yang Z, Lee L, Mikhail M . Attenuation of miR-17∼92 Cluster in Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2015; 12(10):1506-13. PMC: 4627424. DOI: 10.1513/AnnalsATS.201501-058OC. View

Zhang Z, Zhong Y, Li X, Huang X, Du L . Anti-placental growth factor antibody ameliorates hyperoxia-mediated impairment of lung development in neonatal rats. Braz J Med Biol Res. 2020; 53(2):e8917. PMC: 6984382. DOI: 10.1590/1414-431X20198917. View

Zhu F, Li H, Liu Y, Tan C, Liu X, Fan H . miR-155 antagomir protect against DSS-induced colitis in mice through regulating Th17/Treg cell balance by Jarid2/Wnt/β-catenin. Biomed Pharmacother. 2020; 126:109909. DOI: 10.1016/j.biopha.2020.109909. View

Davidson L, Berkelhamer S . Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes. J Clin Med. 2017; 6(1). PMC: 5294957. DOI: 10.3390/jcm6010004. View

Robbins M, Dakhlallah D, Marsh C, Rogers L, Tipple T . Of mice and men: correlations between microRNA-17∼92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2016; 311(5):L981-L984. PMC: 5130535. DOI: 10.1152/ajplung.00390.2016. View

Procianoy R, Hentges C, Silveira R . Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia. Am J Perinatol. 2015; 33(5):480-5. DOI: 10.1055/s-0035-1566294. View

Park D, Park H, Kim Y, Kim H, Jeoung D . HDAC3 acts as a negative regulator of angiogenesis. BMB Rep. 2013; 47(4):227-32. PMC: 4163891. DOI: 10.5483/bmbrep.2014.47.4.128. View

Reiter J, Drummond S, Sammour I, Huang J, Florea V, Dornas P . Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Respir Res. 2017; 18(1):137. PMC: 5506612. DOI: 10.1186/s12931-017-0620-z. View

10.

Sorice R, Ruggiero D, Nutile T, Aversano M, Husemoen L, Linneberg A . Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations. PLoS One. 2012; 7(8):e42537. PMC: 3423400. DOI: 10.1371/journal.pone.0042537. View

11.

Rizq O, Mimura N, Oshima M, Saraya A, Koide S, Kato Y . Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition. Clin Cancer Res. 2017; 23(16):4817-4830. PMC: 5562278. DOI: 10.1158/1078-0432.CCR-16-2735. View

12.

Cramer M, Nagy I, Murphy B, Gassmann M, Hottiger M, Georgiev O . NF-kappaB contributes to transcription of placenta growth factor and interacts with metal responsive transcription factor-1 in hypoxic human cells. Biol Chem. 2005; 386(9):865-72. DOI: 10.1515/BC.2005.101. View

13.

Singh R, Massachi I, Manickavel S, Singh S, Rao N, Hasan S . The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013; 12(12):1160-5. DOI: 10.1016/j.autrev.2013.07.003. View

14.

Chen C, Chen C, Chen J, Zhou L, Xu H, Jin W . Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. Mol Cell Biochem. 2013; 383(1-2):137-48. DOI: 10.1007/s11010-013-1762-z. View

15.

Minamiya Y, Ono T, Saito H, Takahashi N, Ito M, Motoyama S . Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung. Tumour Biol. 2010; 31(5):533-9. DOI: 10.1007/s13277-010-0066-0. View

16.

Chini C, Escande C, Nin V, Chini E . HDAC3 is negatively regulated by the nuclear protein DBC1. J Biol Chem. 2010; 285(52):40830-7. PMC: 3003384. DOI: 10.1074/jbc.M110.153270. View

17.

Gallini F, Arena R, Stella G, Frezza S, Maggio L . Neurodevelopmental outcomes of premature infants with bronchopulmonary dysplasia. Acta Biomed. 2014; 85(1):30-4. View

18.

Cantley M, Zannettino A, Bartold P, Fairlie D, Haynes D . Histone deacetylases (HDAC) in physiological and pathological bone remodelling. Bone. 2016; 95:162-174. DOI: 10.1016/j.bone.2016.11.028. View

19.

Wang Y, Frank D, Morley M, Zhou S, Wang X, Lu M . HDAC3-Dependent Epigenetic Pathway Controls Lung Alveolar Epithelial Cell Remodeling and Spreading via miR-17-92 and TGF-β Signaling Regulation. Dev Cell. 2016; 36(3):303-15. PMC: 4750387. DOI: 10.1016/j.devcel.2015.12.031. View

20.

Ruiz-Camp J, Quantius J, Lignelli E, Arndt P, Palumbo F, Nardiello C . Targeting miR-34a/ interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia. EMBO Mol Med. 2019; 11(3). PMC: 6404112. DOI: 10.15252/emmm.201809448. View